Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2009

View Archived Issues

SASP PT1.2 reduces antibiotic resistance and retains activity when co-applied with other antibiotics

Novel serine/threonine kinase inhibitors discovered by Schering-Plough for cancer treatment

Wyeth presents novel Raf kinase B inhibitors for cancer treatment

Sanofi-aventis presents novel GHS receptor antagonists for the treatment of obesity

GlaxoSmithKline describes novel monoamine reuptake inhibitors as antidepressants

CP-751871 combined with chemotherapy shows promise in phase II trial in NSCLC patients

ITMN-520 prevents airway hyper-responsiveness in murine model of allergen-induced airway dysfunction

EpiCept partners with IDIS for compassionate use Ceplene program

Swissmedic grants approval for clinical study of Neovacs' TNFalpha-kinoid

Pfizer launches Toviaz and YourWay support plan for overactive bladder patients in the U.S.

FDA advisory committee to review ISTA's NDA for Bepreve in June 2009

HHS awards contract to MedImmune to make nasal spray vaccine for H1N1

Celldex enters into definitive agreement to acquire CuraGen

AstraZeneca and Merck & Co. collaborate on novel combination anticancer regimen

Atlantic Healthcare receives EMEA orphan drug status for alicaforsen in pouchitis

NIM-811 may benefit the liver after massive hepatectomy

Cleveland BioLabs concludes initial phase I safety study for CBLB-502

Lilly resubmits Cymbalta supplemental NDA to FDA for chronic pain

Biken launches dry cell-cultured Japanese encephalitis vaccine Jebik V

Phase I results encourage continued study of TRU-016 in chronic lymphocytic leukemia

Clinical study points to oncolytic activity of PF-02341066 in ALK-dependent tumors

TorreyPines Therapeutics' Board of Directors approves of plan of liquidation

AJM-300 benefits some Crohn's disease patients in double-blind trial

NCI initiates phase II clinical trial of Rigel's oral Syk inhibitor R-788 in multiple cancers

Antiinfective Drugs Advisory Committee completes review of ALS' Restanza for CAP

Nuvigil launched for sleepiness associated with several sleeping disorders

Genzyme receives positive CHMP opinion for Mozobil in Europe

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026